The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

Published:2018-11 Issue: Volume:142 Page:143-166
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Johnson Matthew W.,Griffiths Roland R.,Hendricks Peter S.,Henningfield Jack E.

Funder

Heffter Research Institute

NIH

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference215 articles.

1. Lysergic acid diethylamide (LSD-25): XVII. Tolerance development and its relationship to a theory of psychosis;Abramson;J. Psychol.,1956

2. Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects;Abramson;J. Asthma Res.,1965

3. Lysergic acid diethylamide (LSD-25) antagonists: chlorpromazine;Abramson;J Neuropsychiatr,1960

4. A prehistoric mural in Spain depicting neurotropic Psilocybe Mushrooms?1;Akers;Econ. Bot.,2011

5. Diagnostic and Statistical Manual of Mental Disorders;American Psychiatric Association,2013

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Personal Experience Essential for Effective Psychedelic Therapists?: The Challenges of Small, Accumulating Therapist Effects;Psychedelic Medicine;2024-09-01

2. The role of psilocybin in depressive disorders;Current Medical Research and Opinion;2024-08-28

3. Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials;Brain Sciences;2024-08-18

4. Psilocybin for clinical indications: A scoping review;Journal of Psychopharmacology;2024-08-13

5. Psilocybin and chronic neuropathic pain: a systematic review;Regional Anesthesia & Pain Medicine;2024-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3